Charles Womack
Family Medicine · Oklahoma City, OKNPI 1205810702
Payments from drug & device makers
Across 449 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AstraZeneca$992
- AbbVie$708
- Lilly USA, LLC$673
- Amgen$662
- GSK$641
- plus $5K from 32 others
What the payments were for
- Travel & lodging$40%
- Food & beverage$9,710100%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 39 | $1,092 |
| AstraZeneca | 37 | $992 |
| AbbVie(2 entities) | 34 | $708 |
| Lilly USA, LLC | 47 | $673 |
| Amgen(2 entities) | 21 | $662 |
| GSK | 42 | $641 |
| Amarin Pharma, Inc. | 23 | $559 |
| Sanofi-aventis U.S. LLC | 11 | $445 |
| Merck | 40 | $386 |
| Novo Nordisk | 25 | $349 |
| Bayer | 16 | $343 |
| Pfizer | 23 | $339 |
| Abbott | 10 | $298 |
| Boehringer Ingelheim | 15 | $264 |
| Biohaven Pharmaceuticals, Inc. | 2 | $223 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $218 |
| Astellas Pharma US Inc | 8 | $208 |
| Johnson & Johnson | 2 | $161 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $140 |
| Jazz Pharmaceuticals Inc. | 3 | $120 |
| Corium, LLC | 2 | $119 |
| Bristol Myers Squibb | 1 | $119 |
| Scilex Pharmaceuticals Inc. | 5 | $100 |
| Corcept Therapeutics | 1 | $86 |
| Dexcom, Inc. | 4 | $83 |
| Sunovion Pharmaceuticals Inc. | 7 | $77 |
| Upsher-smith Laboratories LLC | 3 | $61 |
| Exact Sciences | 3 | $47 |
| Genentech USA, Inc. | 2 | $34 |
| Eisai Inc. | 2 | $30 |
| Kyowa Kirin, Inc. | 2 | $30 |
| Nevro Corp. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Harmony Biosciences LLC | 1 | $21 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$347
- Otezla$235
- Vascepa$213
- FARXIGA$213
- FreeStyle Libre$129
- SOLIQUA 100/33$116
- Kerendia$116
- VRAYLAR$113
- AIMOVIG$113
- TRULANCE$112
- XIFAXAN$112
- MYRBETRIQ$111
- BREZTRI AEROSPHERE$110
- Azstarys$103
- INVOKANA$102
- TOUJEO$100
How this compares
$9,740 in reported general payments places this provider in the 90th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Oklahoma City
- Carl GriffinOklahoma City$28.2M
- Alexander FrankOklahoma City$3.1M
- Charles LunnOklahoma City$1.4M
- Hieu NguyenOklahoma City$238K
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- Brett CauthenOklahoma City$77K
- Angelique BarretoOklahoma City$74K
- John PittmanOklahoma City$39K
- Terrence TruongOklahoma City$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.